<DOC>
	<DOCNO>NCT01994083</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability IX-01 multiple dos , determine body handle IX-01 .</brief_summary>
	<brief_title>A Study Multiple Oral Doses IX-01 Healthy Men</brief_title>
	<detailed_description />
	<criteria>A body mass index ( Quetelet index ) range 1830 Total body weight great ( &gt; ) 50 kilogram ( kg ) screen Able understand nature trial hazard participate Able communicate satisfactorily investigator participate , comply requirement , entire trial Participants partner must willing use adequate form contraception comply contraception requirement trial , 4 month last dose medication Must plan donate sperm father child trial , 4 month final dose medication Clinically relevant abnormal history , physical finding , electrocardiogram ( ECG ) , laboratory value screen assessment could interfere objective trial safety participant Presence acute chronic illness history chronic illness sufficient invalidate participation trial make unnecessarily hazardous Impaired gastrointestinal , endocrine , thyroid , hepatic , cardiovascular , respiratory , haematological , renal neurological function , diabetes mellitus , coronary heart disease , history psychotic mental illness Surgery ( example ( e.g . ) stomach bypass ) medical condition might affect absorption , metabolism elimination medicine Presence history severe adverse reaction drug Use prescription overthecounter medicine 14 day first dose trial medication , intention use medicine trial , exception short course medication consider investigator interfere safety participant integrity trial data ( acetaminophen ( paracetamol ) ) Current use herbal remedy nutritional supplement , intention use product study Participation another clinical trial new chemical entity prescription medicine within previous 3 month Previous participation trial clinical trial oxytocin receptor antagonist Presence history drug alcohol abuse , intake 21 unit alcohol weekly 5 cigarette daily Blood pressure heart rate supine position screen examination outside range 90130 millimeter mercury ( mm Hg ) systolic , 5090 mm Hg diastolic ; heart rate 5090 beats/minute Possibility participant cooperate requirement protocol Evidence drug abuse urine test Positive test hepatitis B , hepatitis C , Human Immunodeficiency Virus 1 ( HIV1 ) Human Immunodeficiency Virus 2 ( HIV2 ) Loss 400 milliliter ( mL ) blood 3 month trial , e.g . blood donor Objection General Practitioner ( GP ) , medical ground , participant enter trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>